Commercially available dentifrices containing lactoperoxidase have been subjected to clinical trials involving participants from various age groups with various clinical conditions, e.g., malodor [159,160], xerostomia [161], caries [3], and chronic periodontitis [4], as well as healthy subjects [101,141,162,163,164]. The gene discussed is LPO; the disease is xerostomia.